Stem cell research agency awards $37.3 million to aid UC Irvine efforts

September 06, 2012
Neurobiologists Frank LaFerla and Mathew Blurton-Jones study how stem cells restore memory in Alzheimer’s disease.

Efforts to begin human clinical trials using stem cells to treat Alzheimer’s disease and retinitis pigmentosa received a $37.3 million boost from the California Institute for Regenerative Medicine during its most recent round of funding on Sept. 5.

UC Irvine scientists will be part of two research teams garnering CIRM Disease Team Therapy Development Awards, which are designed to accelerate collaborative translational research leading to human clinical trials.

The two grants are the second and third awards given to Sue & Bill Gross Stem Cell Research Center scientists. In July, Aileen Anderson and Brian Cummings and StemCells, Inc. received a $20 million commitment to fund the collection of data necessary to establish human clinical trials in the U.S. for cervical spinal cord injury.

Stem cell research agency awards $37.3 million to aid UC Irvine efforts ›

View by Category